The FDA warns of the death of a patient from a stool graft

What is it?

STAT Plus is a premium subscription offering scalable biopharmaceutical market coverage and in-depth scientific reports from a team with decades of experience in the industry.

What is included?

• Authoritative coverage and biopharmaceutical analysis, interviews with industry pioneers, policy analysis and early review of advanced labs and early stage research
• Subscriber Networking Events and Group Discussions Across the Country
• Monthly live subscriber discussions with our reporters and experts in the field
• Discounted tickets for industry events and early access to industry reports